ORBIMED ADVISORS LLC – Chinook Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$39.89M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+12.41%
quarter
Chinook Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +7.01% | 133K shares | 6.73M | $19.66 | 2.02M |
| Q2 2022 | share | Increase | +33.70% | 478K shares | 9.96M | $17.49 | 1.89M |
| Q1 2022 | share | 0.00% | 0 shares | 71K | $16.36 | 1.41M | |
| Q4 2021 | share | Decrease | -0.16% | -2.33K shares | 5.00M | $16.14 | 1.41M |
| Q3 2021 | share | Increase | +6.51% | 86.83K shares | -706K | $12.76 | 1.42M |
| Q2 2021 | share | Increase | +6.70% | 83.8K shares | -592K | $14.12 | 1.33M |
| Q1 2021 | share | 0.00% | 0 shares | -400K | $15.54 | 1.25M | |
| Q4 2020 | share | Increase | 0.00% | 1.25M shares | 19.82M | $15.86 | 1.25M |